Semaglutide

Size

2mg::::::Literature-based research context for laboratory reference only.::::::Semaglutide is a GLP-1 receptor agonist with C18 fatty diacid modification enabling albumin binding and a prolonged half-life (~7 days). Research now covers body weight, cardiovascular outcomes, neuroinflammation, and addiction models.::::::Lau et al., 2015, Journal of Medicinal Chemistry.::::::1812426::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MjYucGRm||||||5mg::::::Literature-based research context for laboratory reference only.::::::Semaglutide is a GLP-1 receptor agonist with C18 fatty diacid modification enabling albumin binding and a prolonged half-life (~7 days). Research now covers body weight, cardiovascular outcomes, neuroinflammation, and addiction models.::::::Lau et al., 2015, Journal of Medicinal Chemistry.::::::1812427::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MjcucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::Semaglutide is a GLP-1 receptor agonist with C18 fatty diacid modification enabling albumin binding and a prolonged half-life (~7 days). Research now covers body weight, cardiovascular outcomes, neuroinflammation, and addiction models.::::::Lau et al., 2015, Journal of Medicinal Chemistry.::::::1812428::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MjgucGRm||||||20mg::::::Literature-based research context for laboratory reference only.::::::Semaglutide is a GLP-1 receptor agonist with C18 fatty diacid modification enabling albumin binding and a prolonged half-life (~7 days). Research now covers body weight, cardiovascular outcomes, neuroinflammation, and addiction models.::::::Lau et al., 2015, Journal of Medicinal Chemistry.::::::1812429::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MjkucGRm||||||30mg::::::Literature-based research context for laboratory reference only.::::::Semaglutide is a GLP-1 receptor agonist with C18 fatty diacid modification enabling albumin binding and a prolonged half-life (~7 days). Research now covers body weight, cardiovascular outcomes, neuroinflammation, and addiction models.::::::Lau et al., 2015, Journal of Medicinal Chemistry.::::::1812430::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MzAucGRm

Research Profile

Selected literature

Research Use Only

This page is provided for laboratory reference and literature review only. The material is not presented as a consumer product, medical treatment, diagnostic tool, or recommendation for human or animal use.

Purity ≥99%

Certificate of Analysis — Third-party tested for purity, ID & quantity on every batch.

View all →

10 Vials / Box · Lyophilized

CAS#:910463-68-2

Semaglutide

Size

Research Profile

Selected literature

Research Use Only

Purity ≥99%

Certificate of Analysis — Third-party tested for purity, ID & quantity on every batch.

View all →

Overview

Semaglutide is presented here as a laboratory reference entry. The Research Profile summarizes literature-based biological context, while this Overview documents the identity record, specification set, preparation format, and quality-reference information available on the page.

The identity block lists CAS number 910463-68-2, molecular formula C₁₈₇H₂₉₁N₄₅O₅₉, and molecular weight 4,113.6 Da. The material record is paired with ≥99% purity information and a lyophilized presentation for reference review.

Available specification labels include . The active selection is ; changing the selector updates the visible specification label and COA lot references while preserving the same research-reference context.

Structure & Identity

CAS Number910463-68-2

Molecular FormulaC₁₈₇H₂₉₁N₄₅O₅₉

Molecular Weight4,113.6 Da

Purity≥99%

Packaging10 Vials / Box, Lyophilized

Storage2–8 °C (short-term), −20 °C (long-term)